Harnessing the Power of Nature to
Create Tomorrow's Molecules
The Future of Biomanufacturing
Invizyne is leading the Cell-Free revolution In Synthetic Biology.
Our pioneering SimplePath platform produces natural chemicals
by reducing complex cellular processes to their essential elements.
simplified pathways to complicated products...
Our Cell-Free Approach:
Traditional Cell-Based Approach:
Unconstrained by complex cellular metabolism we build simple, flexible and modular production systems that are scalable and efficient.
Nature provides us with countless chemicals that can improve our lives. Trees and plants often supply them, but in such small amounts that they’re hard to extract, leading to waste and environmental degradation. To harness natural chemicals more effectively, synthetic biology first attempted to rewire living cells to make them easier to extract. But cells are complicated and not easily rewired.
Invizyne’s new approach, SimplePath streamlines synthetic biology by removing cells altogether, along with their complexities. Using our proprietary, sustainable enzyme systems we can build simple, efficient reactors for chemical production. The Invizyne approach allows for:
Fast design-build-test-learn cycles for rapid optimization
Reliable scaling of production
Simplified product purification
Unleashing enzymes for production outside the cell allows us to achieve the safety, sustainability and diversity found in nature, along with the scale found in traditional chemical manufacturing.
MARKETS & PRODUCTS
Invizyne's pioneering platform has been applied to produce a wide variety of high value and difficult to make target molecules, with exceptional success in cannabinoids, biofuels and terpenes, where we’ve achieved orders of magnitude higher concentrations than what is possible using yeast-based methods.
Contact us to learn more on how we can provide solutions for:
Natural Ingredients: cannabinoids, flavors, fragrances, nutraceuticals
Pharmaceuticals: natural products with therapeutic properties
Chemicals: commodity chemicals, specialty chemicals, biofuels
Our team combines decades of experience in biochemistry, biophysics, molecular biology, engineering, with sound and innovative business practices and principles.
MO HAYAT, JD
TYLER KORMAN, PhD
Director of R&D
PAUL OPGENORTH, PhD
Director of R&D
Scientific Advisory Board
JAMES BOWIE, PhD
Professor Dept of Chemistry and Biochemistry at UCLA
YI TANG, PhD
Chancellor Professor at UCLA
JIM LALONDE, PhD
Formerly SVP of R&D at Codexis